Kestra Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Kestra Advisory Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-1,979	Closed	-$234K	–	3515
2026 Q2	$234K	Buy	+1,979	New	+$214K	﹤0.01%	2988
2026 Q1	–	Sell	-1,833	Closed	-$192K	–	4069
2025 Q4	$192K	Buy	+1,833	New	+$184K	﹤0.01%	2924
2025 Q2	–	Sell	-1,575	Closed	-$136K	–	2950
2025 Q1	$136K	Buy	+1,575	New	+$134K	﹤0.01%	2550

Other funds holding PJP

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

Beacon Harbor Wealth Advisors Virginia Beach, Virginia $526M AUM 34.64% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.16B AUM 42.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Vicus Capital State College, Pennsylvania $1.58B AUM 16.34% 1-Year Est. Return

Joseph Group Capital Management Columbus, Ohio $562M AUM 15.17% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Trilogy Capital Irvine, California $2.61B AUM 14.55% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Kestra Advisory Services's PJP Position: Q3 2026 in Review

Kestra Advisory Services sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2026, closing a stake of 1,979 shares — an estimated $234K sold.

Kestra Advisory Services first reported a position in PJP in Q1 2025 and held it in 3 quarters. The position peaked at $234K in Q2 2026. 75 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

Kestra Advisory Services reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2026 after selling out during the quarter.
Kestra Advisory Services sold 1,979 Invesco Pharmaceuticals ETF shares in Q3 2026, an estimated $234K.
Kestra Advisory Services first reported a position in Invesco Pharmaceuticals ETF in Q1 2025 and held it in 3 quarters.
Kestra Advisory Services's Invesco Pharmaceuticals ETF position peaked at $234K in Q2 2026.
75 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.